XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2023
Fair Value of Financial Instruments  
Fair Value of Financial Instruments

3. Fair Value of Financial Instruments

ASC 820, Fair Value Measurement, establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company’s own assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances.

ASC 820 identifies fair value as the exchange price, or exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a three-tier fair value hierarchy that distinguishes among the following:

Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.
Level 2 – Valuations based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and models for which all significant inputs are observable, either directly or indirectly.
Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The following table presents fair value of the Company’s cash, cash equivalents, restricted cash and warrant liability as of March 31, 2023 and December 31, 2022 (in thousands):

    

March 31, 

Quoted Prices in Active Markets

Significant Other Observable Inputs

Unobservable Inputs

Description:

2023

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets:

 

Cash

$

841

$

841

$

$

Money Market Funds

26,595

26,595

Restricted Cash

 

1,968

 

1,968

 

 

Total assets measured and recorded at fair value

$

29,404

$

29,404

$

$

Liabilities:

 

  

 

  

 

  

 

  

Warrant Liability

 

1,449

 

 

 

1,449

Total liabilities measured and recorded at fair value

$

1,449

$

$

$

1,449

December 31,

Quoted Prices in Active Markets

Significant Other Observable Inputs

Unobservable Inputs

Description:

    

2022

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets:

Cash

$

9,651

$

9,651

$

$

Money Market Funds

 

28,669

28,669

Restricted Cash

1,960

 

1,960

 

 

Total assets measured and recorded at fair value

$

40,280

$

40,280

$

$

Liabilities:

 

  

 

  

 

  

 

  

Warrant Liability

 

5,483

 

 

 

5,483

Total liabilities measured and recorded at fair value

$

5,483

$

$

$

5,483

(1)The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.

The Company recognizes transfers between levels of the fair value hierarchy as of the end of the reporting period. There were no transfers between Level 2 and Level 3 during the three months ended March 31, 2023.

The common stock warrants issued in connection with the Company’s equity raises in July 2022 and November 2022 were classified as liabilities at the time of issuance due to certain cash settlement adjustment features that were not deemed to be indexed to the Company’s stock. The warrant liability is remeasured each reporting period with the change in fair value recorded to other income (expense) in the consolidated statement of operations and comprehensive loss until the warrants are exercised, expired, reclassified or otherwise settled. The fair value of the pre-funded warrant liability is equal to its intrinsic value due to the nominal exercise price. The fair value of the warrant liability was estimated using a Black-Scholes Option Pricing Model.

Registered Direct Stock Offering and Concurrent Warrant Issuance

The fair value of the July Offering Common Stock Warrant liability was determined using Level 3 inputs and was estimated using the Black-Scholes valuation model. The assumptions used to estimate the fair value were as follows:

    

March 31

    

December 31,

    

    

2023

    

2022

Expected term of warrants (in years)

4.3

4.6

Risk-free interest rate

3.7

%  

4.0

%  

Expected volatility

94.4

%  

108.9

%  

Dividend yield

%  

%  

The following is a roll forward of the July Offering Common Stock Warrant liability (in thousands):

Balance, December 31, 2022

$

259

Change in fair value

 

(191)

Balance, March 31, 2023

$

68

November 2022 Equity Offering and Warrant Issuance

Due to the nominal exercise price of the pre-funded warrants, the fair value is equal to the intrinsic value. The fair value of the November Offering Common Stock Warrant liability was determined using Level 3 inputs and was estimated using the Black-Scholes valuation model. The assumptions used to estimate the fair value were as follows:

 

    

March 31, 2023

    

December 31, 2022

 

Expected term of warrants (in years)

4.6

4.9

Risk-free interest rate

 

3.6

%  

4.0

%  

Expected volatility

 

100.2

%  

106.1

%  

Dividend yield

 

%  

%  

The following is a roll forward of the November Offering Common Stock Warrant liability (in thousands):

    

Warrant Liability

Balance, December 31, 2022

$

5,224

Change in fair value

 

(2,275)

Exercise of pre-funded common stock warrants

(1,568)

Balance, March 31, 2023

$

1,381

Warrants

As of March 31, 2023, the Company had the following common stock warrants outstanding:

Classification

Warrants

Exercise Price

Expiration Date

July 2022 Offering

Liability

320,000

$6.58

12/28/2027

November 2022 Offering (Pre-funded warrants)

Liability

619,000

0.001

Until exercised

November 2022 Offering

Liability

2,614,380

2.95

 

11/18/2027

R-Bridge warrants

Equity

200,000

20.50

4/14/2025

Other warrants

Equity

11,014

31.25 - 265.48

1/29/24 - 3/31/27

3,764,394

The Company classifies investments available to fund current operations as current assets on its balance sheet. As of March 31, 2023 and 2022, the Company did not hold any investment securities exceeding a one-year maturity.

Accretion of bond discount on marketable securities is included in other income as a separate component of other income (expense) on the statement of operations and comprehensive loss. Interest income on marketable securities is recorded as interest income on the statement of operations and comprehensive loss.